Dual PI3K/HDAC Inhibitor BEBT-908 Exhibits Potent Efficacy as Monotherapy for Primary Central Nervous System Lymphoma.

Detalles Bibliográficos
Publicado en:	Targeted Oncology Vol. 18; no. 6; pp. 941 - 953
Autores principales:	Wang, Ning, Mo, Zhenxian, Pan, Lu, Zhou, Minhua, Ye, Xiaolan, Liu, Xinjian, Cai, Xiong, Qian, Changgeng, Chen, Feili, Xiong, Yan, Fan, Fushun, Li, Wenyu
Formato:	Journal Article
Publicado:	Springer Nature Nov2023
Acceso en línea:	Ver este registro en EBSCOhost